efavirenz and warfarin
efavirenz has been researched along with warfarin in 10 studies
Research
Studies (10)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Xie, L; Zhou, T | 1 |
| Bonora, S; Concia, E; D'Avolio, A; Di Perri, G; Lanzafame, M; Lattuada, E; Trentini, L | 1 |
| Amunugama, H; Ballou, DP; Hollenberg, PF; Kenaan, C; Sridar, C; Zhang, H | 1 |
| Anderson, AM; Chane, T; Chen, S; Easley, KA; Patel, M; Xue, W | 1 |
| Antunes, AM; Harjivan, SG; Marques, MM; Pereira, SA; Wanke, R | 1 |
| Allayeh, AK; Batran, RZ; Kassem, AF; Khedr, MA; Pannecouque, C; Sabt, A | 1 |
Reviews
2 review(s) available for efavirenz and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Progress in HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Coumarins; Cyclopropanes; Delavirdine; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Conformation; Molecular Structure; Nevirapine; Oxazines; Pyranocoumarins; Reverse Transcriptase Inhibitors | 2004 |
Other Studies
8 other study(ies) available for efavirenz and warfarin
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment.
Topics: Adult; Aged; Alkynes; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2C9; Drug Interactions; Female; Humans; Lopinavir; Male; Pyrimidinones; Ritonavir; Warfarin | 2008 |
Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex
Topics: Alkynes; Animals; Anti-HIV Agents; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Bupropion; Catalysis; Chlorocebus aethiops; COS Cells; Coumarins; Cyclopropanes; Cytochrome P-450 CYP2B6; Electron Transport; Escherichia coli; Ferric Compounds; Genetic Variation; Kinetics; Mutagenesis; Mutation; NADPH-Ferrihemoprotein Reductase; Oxidoreductases, N-Demethylating; Polymorphism, Genetic; tert-Butylhydroperoxide | 2011 |
Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals.
Topics: Adult; Alkynes; Anti-HIV Agents; Anticoagulants; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Drug Interactions; Female; HIV Seropositivity; Humans; International Normalized Ratio; Lopinavir; Male; Medication Adherence; Patient-Centered Care; Retrospective Studies; Ritonavir; Thromboembolism; Treatment Outcome; United States; Venous Thrombosis; Warfarin | 2012 |
The role of competitive binding to human serum albumin on efavirenz-warfarin interaction: a nuclear magnetic resonance study.
Topics: Alkynes; Anti-HIV Agents; Anticoagulants; Benzoxazines; Binding, Competitive; Cyclopropanes; Drug Interactions; Humans; Magnetic Resonance Spectroscopy; Serum Albumin; Serum Albumin, Human; Warfarin | 2013 |
4-Phenylcoumarin derivatives as new HIV-1 NNRTIs: Design, synthesis, biological activities, and computational studies.
Topics: Anti-HIV Agents; Coumarins; Drug Design; HIV Reverse Transcriptase; HIV-1; Molecular Docking Simulation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2023 |